Skip to main content

Market Overview

CRISPR Therapeutics AG (CRSP)

125.69 -1.59 (-1.25%)

Analyst Ratings

DateResearch FirmActionCurrentPT
2/17/21OppenheimerMaintainsOutperform187.0
12/10/20Chardan CapitalMaintainsBuy166.0
12/10/20NeedhamMaintainsBuy170.0
12/07/20Roth CapitalMaintainsBuy170.0
12/07/20Wells FargoDowngradesEqual-Weight145.0
10/29/20Piper SandlerMaintainsOverweight107.0
10/23/20RBC CapitalInitiates Coverage OnSector Perform110.0
10/22/20Chardan CapitalMaintainsBuy110.0
10/05/20B of A SecuritiesInitiates Coverage OnBuy110.0
7/28/20BarclaysMaintainsOverweight102.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter